Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2016

Feb 24, 2016

30597_dirs_2016-02-24_820b593c-8492-4a05-8a33-d765ee32519a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2016-02-22

Reporting Person: ARORA MANEESH (Director, COO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-22 Common Stock M 7225 $0.00 Acquired 257590 Direct
2016-02-23 Common Stock S 2556 $6.39 Disposed 255034 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-02-22 Restricted Stock Units $ M 7225 Disposed Common Stock (7225) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 12359 Indirect
Common Stock 65000 Indirect

Footnotes

F1: Represents shares of common stock received upon vesting of a restricted stock unit award.

F2: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain shares of restricted stock on February 22, 2016.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock.

F4: Represents a restricted stock unit award granted on February 22, 2013 that partially vested on February 22, 2016. The restricted stock units vest in four equal annual installments beginning on February 22, 2014.